Search for Abstracts Find by Title, Author or Description Year Abstracts - 2022 - 2021 - 2020 - 2019 - 2018 - 2017 - 2016 - 2015 - 2014 - 2013 - 2012 - 2011 - 2010 - 2009 Tags AB Applied Basic Science Basic Science BT Clinical Clinical-Chemotherapy-SSA-Biologics Clinical-PRRT-Nuclear Clinical-Surgical-Applied_Pathology OT Other P Population Science Poster T Trials In Progress Search Reset Order by Title Alphabetical Title Reverse Alphabetical Most Recent First Oldest First Most popular first Last modified first 2022 Symposium Abstract Poster Quick Guide Published in 2022 Download [B10] Schwarz - Inhibition of Estrogen Receptor Alpha Radiosensitizes Neuroendocrine Tumors Published in 2022 Listed under Basic Science Download [B11] Cortez - Patient-Derived Organoids and Their Potential for Precision Medicine in Neuroendocrine Tumors Published in 2022 Listed under Basic Science Download [B12] Herring - Transcriptomic Influences of Racial Disparities in Black Patients with Pancreatic Neuroendocrine Tumors Published in 2022 Listed under Basic Science Download [B13] DePietro - Optical Genome Mapping: a Novel Approach to Identifying Structural Variants in Metastatic Neuroendocrine Tumors Published in 2022 Listed under Basic Science Download [B14] Amin - Pancreatic Mixed Acinar-Neuroendocrine Carcinoma: a Single Institutional Genomic Characterization Report Published in 2022 Listed under Basic Science Download [B15] Scotto - Targeting the TCA Cycle with Histone Deacetylase and Nicotinamide Phosphoribosyltransferase Inhibitors Uncovers a Critical Role for YAP1 in Neuroendocrine Cells Published in 2022 Listed under Basic Science Download [B16] Schultz - [212Pb]PSC-PEG2-TOC Therapy for NET Leads to Complete Responses in Mice Bearing SSTR2 Positive Tumors – Comparison to [177Lu]DOTATATE in a Preclinical Model Published in 2022 Listed under Basic Science Download [B1] Rajhans - Single-Cell ATAC and Single-Nucleus RNA Sequencing Uncovers Cellular Heterogeneity Within Pancreatic Neuroendocrine Tumors Published in 2022 Listed under Basic Science Download [B2] Madigan - Multiple Layers of Epigenetic Regulation Cooperate to Silence Expression of Somatostatin Receptor Type 2 in Pancreatic Neuroendocrine Tumors Published in 2022 Listed under Basic Science Download [B3] Pelle - Development of a Novel Anti-SSTR Bispecific T-Cell Engager (BiTE)-like Molecule for the Treatment of Neuroendocrine Tumors Published in 2022 Listed under Basic Science Download [B4] Whitt - Simultaneous Inhibition of DNA Methylation and Histone De-acetylation for Enhanced SSTR2 Expression In Vitro Published in 2022 Listed under Basic Science Download [B5] Hallenbeck - Oncolytic Seneca Valley Virus (SVV-001) Overcomes Checkpoint Inhibitor Resistance and Demonstrates a Systemic Anti-tumor Response in a Syngeneic Tumor Model Published in 2022 Listed under Basic Science Download [B6] Guenter - Detecting Cell Surface Expression of Calreticulin in Pancreatic Neuroendocrine Tumors Using a Novel [68Ga]-Radiolabeled Peptide Published in 2022 Listed under Basic Science Download [B7] Williams - All-Trans Retinoic Acid Radiosensitizes Neuroendocrine Tumor Cells via Peptidyl-Prolyl Cis- Trans Isomerase 1 Inhibition Published in 2022 Listed under Basic Science Download [B8] Kaemmer - CDK4/6-MEK Targeted Therapy Causes Regression and Reduced Metastatic Colonization of Pancreatic Neuroendocrine Tumors Published in 2022 Listed under Basic Science Download [B9] Chen - Deletion of Notch1 Signaling in Pancreatic Neuroendocrine Tumors Reduces Metastatic Properties Published in 2022 Listed under Basic Science Download [C10] Pelle - ACTH-secreting Pancreatic Neuroendocrine Neoplasms: A Case-Series Published in 2022 Listed under Clinical Download [C11] Orenbach - Results from the Phase 1, Randomized, Open-Label, Cross-Over Study to Evaluate Pharmacokinetics of Three Escalating Doses of Oral Octreotide Capsules Published in 2022 Listed under Clinical Download [C12] Roy - Financial Toxicity and Supportive Care in Neuroendocrine Tumor: A Biobank Study Published in 2022 Listed under Clinical Download [C13] Blanford - Serum Serotonin Compared to Plasma 5-HIAA and Chromogranin A as Biomarkers of Response to Hepatic Artery Bland Embolization Published in 2022 Listed under Clinical Download [C14] Lee - Cardiac Neuroendocrine Tumor Metastases on 68Ga- DOTATATE PET/CT Published in 2022 Download [C15] Delpassand - Effectiveness and Safety of Re-Treatment with 177Lu- DOTATATE in Patients With Progressive NETs in the US: a Retrospective Real-World Study Published in 2022 Listed under Clinical Download [C16] Ensign - Clinical Utility of Somatostatin Receptor Positron Emission Tomography Imaging Biomarkers for Characterization of Meningioma Among Incidental Central Nervous System Lesions Published in 2022 Download [C17] Soulen - Integration of Radioembolization with CapTem for Liver-Dominant G2 NETs: Long-Term Outcomes Published in 2022 Download [C18] Soulen - Radiosensitization for TARE: Does Duration of Chemotherapy Affect PFS? Published in 2022 Listed under Clinical Download [C19] Cordero - Hernandez - Transformation of G1-G2 Neuroendocrine Tumors (NETs) to Neuroendocrine Carcinomas (NECs) Following Peptide Receptor Radionuclide Therapy (PRRT): A Case Series Published in 2022 Download [C1] Singh - Progression-Free Survival in Patients with Bronchopulmonary Neuroendocrine Tumors Treated with Lanreotide or Placebo: Adjustment for Crossover Effects in Placebo Arm Published in 2022 Listed under Clinical Download [C20] Jimenez - Quality of Life Assessments for Advanced Pheochromocytoma and Paraganglioma Patients that Received High-Specific-Activity I-131 MIBG: Results from a Pivotal Phase 2 Clinical Trial Published in 2022 Listed under Clinical Download [C21] Coston - Characterizing Bone Metastases in Patients with Well-Differentiated Neuroendocrine Neoplasms Utilizing Ga68-DOTATATE PET Published in 2022 Listed under Clinical Download [C22] Prela - The Role of 68Ga-DOTATATE PET/CT in the Management of Gastrointestinal and Pancreatic Neuroendocrine Tumors Published in 2022 Listed under Clinical Download [C23] Al-Toubah - Somatostatin Receptor Expression in Lung Neuroendocrine Tumors: An Analysis of Dotatate PET Scans Published in 2022 Listed under Clinical Download [C24] Mittra - MIBG and DOTATATE Therapy for Pheochromocytoma and Paraganglioma: A Single Institution Experience Published in 2022 Listed under Clinical Download [C25] Heying - Evaluation of 68Ga-DOTATATE PET After Two Cycles of Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NET) Published in 2022 Listed under Clinical Download [C26] Mallak - Pre-therapy Functional Imaging with MIBG and DOTATATE to Guide Radiopharmaceutical Therapy for Pheochromocytoma and Paraganglioma: A Single Institution Experience Published in 2022 Listed under Clinical Download [C27] Jha - Performance of 68Ga-DOTATATE PET/CT, 18F-FDG PET/CT, CT, and MRI Spine in the Detection of Spinal Bone Metastases in Metastatic Pheochromocytoma/Paraganglioma Published in 2022 Listed under Clinical Download [C28] Jha - Diagnostic Performance of PET or PET/CT Utilizing 18F-DOPA, 68Ga-DOTATATE, 18F-FDG, 18F-FDA, and CT and MRI in the Detection of MEN2A-relatedpheochromocytoma Published in 2022 Listed under Clinical Download [C29] Jha - Diagnostic Performance of PET or PET/CT Utilizing 18F-DOPA, 68Ga-DOTATATE, 18F-FDG, 18F-FDA, and CT and MRI the Detection of VHL-related Pheochromocytoma Published in 2022 Listed under Clinical Download [C2] Hunter - Pembrolizumab for the Treatment of Recurrent High Grade Neuroendocrine Neoplasms Published in 2022 Listed under Clinical Download [C30] Meloche-Dumas - Liver-Directed Therapy of Neuroendocrine Liver Metastases Published in 2022 Listed under Clinical Download [C31] Patel - Goblet Cell Adenocarcinoma (GCA) of the Appendix: Interrogating Proteomics to Identify Potential Actionable Targets Published in 2022 Listed under Clinical Download [C32] Ziogas - Surgical Management of G3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis Published in 2022 Listed under Clinical Download [C33] Taherian -High-Grade Pancreatic Neuroendocrine Neoplasms: Interobserver Diagnostic Accuracy and Relationship with Clinicopathological and Molecular Characteristics Published in 2022 Download [C34] Byun - Grade Creep and the Importance of Tissue Sampling: Changes in Ki-67 and Grade in Serial Neuroendocrine Tumor Samples Published in 2022 Download [C35] Limbach - Liver Directed Therapy is Associated with Improved Survival in Metastatic Gastroenteropancreatic Neuroendocrine Neoplasms with Concurrent Bone Metastasis Published in 2022 Listed under Clinical Download [C37] Borbon - Is There a Role for Surgical Resection of Grade 3 Neuroendocrine Neoplasms? Published in 2022 Listed under Clinical Download [C38] Concors - Increased Incidence, Prevalence, and Surgical Management of Enteropancreatic Neuroendocrine Tumors Is Associated with Improvements in Survival - A Contemporary Analysis Published in 2022 Listed under Clinical Download [C39] McElroy - Have We Accounted for Asians? A Critical Analysis of Racial Cancer Disparity Amongst Asian Pancreatic Neuroendocrine Tumor Patients Published in 2022 Listed under Clinical Download [C3] Clarke - Real World Analysis of Long-Acting Somatostatin Analog (LA-SSA) Treatment and Dose Escalation Among Patients with Neuroendocrine Tumors (NET) Published in 2022 Download [C40] Joseph - TP53 Mutation Portends a Worse Overall Survival in Patients with Advanced Grade 3 Well-Differentiated Neuroendocrine Tumors Published in 2022 Listed under Clinical Download [C41] Chauhan - SSTR-2 Expression in Solid Tumors: An Immunohistochemistry Analysis Published in 2022 Listed under Clinical Download [C42] Pai - Small Intestinal NET Recurrence – When Why and How? Published in 2022 Listed under Clinical Download [C43] Lui - Post-Operative Biochemical Surveillance Thresholds Can be Used to Monitor for Sympathetic Pheochromocytoma/Paraganglioma Recurrence and Metastasis Published in 2022 Listed under Clinical Download [C4] McLaughlin - Cisplatin vs Carboplatin in Extrapulmonary Poorly Differentiated Neuroendocrine Carcinomas (PD NEC) Published in 2022 Listed under Clinical Download [C5] Ghosh - c-MET Expression in MEN1-associated Neuroendocrine Tumors Published in 2022 Listed under Clinical Download [C6] Eads - An Open-Label, Phase 1b/2 study of Surufatinib in Combination with Tislelizumab in Patients with Advanced Neuroendocrine Tumors Published in 2022 Listed under Clinical Download [C7] Al-Toubah - Risk of Myelodysplastic Syndrome/Acute Leukemia with Sequential Capecitabine/Temozolomide and 177Lu-Dotatate Published in 2022 Listed under Clinical Download [C8] Al-Toubah - Phase II Study of Pembrolizumab and Lenvatinib in Advanced Well-Differentiated Neuroendocrine Tumors Published in 2022 Listed under Clinical Download [C9] Lee - Correlation of MEN1 and DAXX Mutational Status with Response to Capecitabine and Temozolomide (CAPTEM) in Pancreatic Neuroendocrine Tumors Published in 2022 Listed under Clinical Download [O10] Sonbol - Germline Cancer Testing in Unselected Patients with Neuroendocrine Neoplasms: A Multi-center Prospective Study Published in 2022 Listed under OT Download [O11] Rose-Krasnor - Pheo Para Alliance Patient Centered Research on Challenges for Those with Pheochromocytoma and Paraganglioma Published in 2022 Listed under OT Download [O12] Trikalinos - An Appraisal of Findings from a Neuroendocrine Neoplasm (NEN) Tumor Board (TB): Is There Added Value or Is It Redundant? Published in 2022 Listed under OT Download [O1] Das - Efficacy and Toxicity of Anti-Vascular Endothelial Growth Factor (VEGF) Receptor Tyrosine Kinase Inhibitors (TKIs) in Neuroendocrine Tumors (NETs) – A Systematic Review and Meta-Analysis Published in 2022 Listed under OT Download [O2] Duncan - The Association Between Patient-Reported Symptom Burden and Urgent Healthcare Use in Patients Diagnosed with Neuroendocrine Tumors Published in 2022 Listed under OT Download [O3] Moon - Germline Pathogenic Variants in Patients with High- Grade (G3) Metastatic Gastroenteropancreatic (GEP) Neuroendocrine Neoplasms (NENs) Published in 2022 Listed under OT Download [O4] Alaklabi - Immune Cell Molecular Pharmacodynamics of Lanreotide in Relation to Treatment Response Published in 2022 Listed under OT Download [O5] Benard - Implementation of a Patient Advisor Program for Neuroendocrine Tumor Patients: Acceptability, Benefits and Potential Challenges Published in 2022 Listed under OT Download [O6] Ramirez - Frequency of Pulmonary Carcinoid Tumor Research Presented at Major International Neuroendocrine and Lung Cancer Scientific Meetings Published in 2022 Listed under OT Download [O7] Hunter - Circulating Tumor DNA Detection Using a Personalized, Tumor-Informed Assay in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumor Patients Published in 2022 Listed under OT Download [O8] Moon - Variants of Uncertain Significance (VUS) are More Common in Non-Caucasian Patients with Neuroendocrine Neoplasms (NENs) Published in 2022 Listed under OT Download [O9] Lou - Leveraging Transcriptomics to Grade Pancreatic Neuroendocrine Neoplasms(NENs) and Assess Molecular Alterations Associated with Somatostatin Receptor(SSTR) Subtype Expression Published in 2022 Listed under OT Download [P10] Ituarte - Environmental Pollution and GEP-NENS – Is There an Association? Published in 2022 Listed under P Download [P1] Diamantopoulous - Cervical Neuroendocrine Carcinomas: A Population- Based Analysis of Clinicopathologic Characteristics and Survival Outcomes in Comparison with Conventional Cervical Malignancies Published in 2022 Listed under P Download [P2] Chu - Factors Impacting Survival Outcomes of Islet Cell Carcinoma Published in 2022 Listed under P Download [P3] Hu - Socioeconomic Factors, Treatment Modality, and Survival in Islet Cell Carcinoma: A National Cancer Database Analysis Published in 2022 Download [P5] Laderian - Comparison of Demographics and Overall Survival (OS) Among Patients with Young-Onset(YO) and Late- Onset(LO) GI Neuroendocrine Tumors/Carcinomas (NETs/NECs) in the United States Published in 2022 Listed under P Download [P6] Ackbarali - Evaluating the Impact of Education on Clinician Integration of Guidelines, Real-World Data, and Patient Perspectives on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) Published in 2022 Listed under P Download [P7] Mulvey - Feasibility of e-NET: A Web-Based Health Platform to Investigate Quality of Life in Patients with Neuroendocrine Tumors Published in 2022 Listed under P Download [P8] Hernandez - Multivisceral Surgical Resection of Locally Advanced Pancreatic Neuroendocrine Tumor is Associated with a Survival Benefit Published in 2022 Listed under P Download [P9] Bogaards - Lifestyle and Neuro-endocrine Tumor (NET) Development Within the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort Published in 2022 Listed under P Download [T10] Mohamed - Pilot Study of TQ Formula in Combination with Nivolumab and Ipilimumab in Metastatic Gastroenteropancreatic Neuroendocrine Carcinomas (GEP-NECAs) Published in 2022 Listed under T Download [T1] Stockton - Phase Ia/Ib Study of BAY1895344 Plus Topoisomerase I Inhibitors with a Focus on Poorly Differentiated Neuroendocrine Carcinomas and Pancreatic Adenocarcinoma Published in 2022 Listed under T Download [T2] Halfdanarson - COMPOSE: Pivotal Phase III Trial for Well- Differentiated Aggressive Grade 2/3 Gastroenteropancreatic Neuroendocrine Tumors Comparing 177Lu-edotreotide with Best Standard of Care Published in 2022 Listed under T Download [T3] Chauhan - Phase 2 Study to Evaluate the Safety, Pharmacokinetics, and Dose Response of Paltusotine Carcinoid Syndrome Published in 2022 Listed under T Download [T4] McGarrah - Phase 1-2 Trial of Vesicular Stomatitis Virus Expressing Human Interferon-β and NIS (VSVIFNβ- NIS), with Pembrolizumab, in Patients with Neuroendocrine Carcinoma Published in 2022 Listed under T Download [T5] Jimenez - A Phase 2 Open-Label Study of Belzutifan (a HIF-2α Inhibitor) Monotherapy in Patients with Advanced/Metastatic Pheochromocytoma/ Paraganglioma or Pancreatic Neuroendocrine Tumors Published in 2022 Listed under T Download [T6] Hope - ACTION-1: A Randomized Phase Ib/3 trial of RYZ101 Compared with SoC in SSTR2+ Well-Differentiated GEP-NET with Progression Following Lu-177 SSA Published in 2022 Listed under T Download [T7] Singh - Methodology of the SORENTO Clinical Trial: Assessing Efficacy and Safety of High Exposure Octreotide Subcutaneous Depot in Patients with GEP-NET Published in 2022 Listed under T Download [T8] Chauhan - Phase II Trial Evaluating [177Lu]Lu-DOTA-TATE in Adolescents with Somatostatin Receptor (SSTR)- positive Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs), Pheochromocytomas and Paragangliomas (PPGLs) Published in 2022 Listed under T Download [T9] Puranik - PReCedeNT Trial: Phase III Randomised Controlled Trial of PRRT with Lutetium – 177 DOTATATE Plus Chemotherapy Versus PRRT Alone in FDG-avid, Well-Differentiated Gastro-Entero-Pancreatic Neuroendocrine Tumors Published in 2022 Listed under T Download Select the number of documents per page 5 10 15 20 25 30 50 100
